Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1233 entries
Sorted by: Best Match Show Resources per page
Diploid males support a two-step mechanism of endosymbiont-induced thelytoky in a parasitoid wasp

STEM and males

Ma WJ, Pannebakker BA.
GSID: vYpTCrVAJoAJ
WJ Ma, BA Pannebakker, L van de Zande… - BMC Evolutionary …, 2015 - Springer

… had mated with sexual AO males (glm, Turkey contrast, all P < 0.001). These high proportions of female offspring are unlikely to stem from mortality of males as a consequence of hybrid …

Cite
Ma, W. J., Pannebakker, B. A., van de Zande, L., Schwander, T., Wertheim, B., & Beukeboom, L. W. (2015). Diploid males support a two-step mechanism of endosymbiont-induced thelytoky in a parasitoid wasp. BMC Evolutionary Biology, 15(1), 1-12.
Ma, Wen-Juan, et al. "Diploid males support a two-step mechanism of endosymbiont-induced thelytoky in a parasitoid wasp." BMC Evolutionary Biology 15.1 (2015): 1-12.
Copy Download .nbib Format: MLA
Genome-wide Identification, Characterization, and Expression Analysis of PHT1 Phosphate Transporters in Wheat.

Frontiers in plant science

Teng W, Zhao YY, Zhao XQ, He X, Ma WY, Deng Y, Chen XP, Tong YP.
PMID: 28443126
Front Plant Sci. 2017 Apr 11;8:543. doi: 10.3389/fpls.2017.00543. eCollection 2017.

The PHT1 family of phosphate (Pi) transporters mediates phosphorus (P) uptake and re-mobilization in plants. A genome-wide sequence analysis of

Cite
Teng W, Zhao YY, Zhao XQ, et al. Genome-wide Identification, Characterization, and Expression Analysis of PHT1 Phosphate Transporters in Wheat. Front Plant Sci. 2017;8:543doi: 10.3389/fpls.2017.00543.
Teng, W., Zhao, Y. Y., Zhao, X. Q., He, X., Ma, W. Y., Deng, Y., Chen, X. P., & Tong, Y. P. (2017). Genome-wide Identification, Characterization, and Expression Analysis of PHT1 Phosphate Transporters in Wheat. Frontiers in plant science, 8543. https://doi.org/10.3389/fpls.2017.00543
Teng, Wan, et al. "Genome-wide Identification, Characterization, and Expression Analysis of PHT1 Phosphate Transporters in Wheat." Frontiers in plant science vol. 8 (2017): 543. doi: https://doi.org/10.3389/fpls.2017.00543
Teng W, Zhao YY, Zhao XQ, He X, Ma WY, Deng Y, Chen XP, Tong YP. Genome-wide Identification, Characterization, and Expression Analysis of PHT1 Phosphate Transporters in Wheat. Front Plant Sci. 2017 Apr 11;8:543. doi: 10.3389/fpls.2017.00543. eCollection 2017. PMID: 28443126; PMCID: PMC5386973.
Copy Download .nbib Format: NLM
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

Annals of oncology : official journal of the European Society for Medical Oncology

O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler AL, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazemzadeh R, Rarick M, Cohen DJ, Radford J, Fehrenbacher L, Bajaj R, Bathini V, Fanta P, Berlin J, McRee AJ, Maguire R, Wilhelm F, Maniar M, Jimeno A, Gomes CL, Messersmith WA.
PMID: 26945010
Ann Oncol. 2016 Jun;27(6):1180. doi: 10.1093/annonc/mdw095. Epub 2016 Mar 03.

No abstract available.

Cite
O'Neil BH, Scott AJ, Ma WW, et al. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Ann Oncol. 2016;27(6):1180doi: 10.1093/annonc/mdw095.
O'Neil, B. H., Scott, A. J., Ma, W. W., Cohen, S. J., Aisner, D. L., Menter, A. R., Tejani, M. A., Cho, J. K., Granfortuna, J., Coveler, A. L., Olowokure, O. O., Baranda, J. C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D. J., Radford, J., Fehrenbacher, L., Bajaj, R., Bathini, V., Fanta, P., Berlin, J., McRee, A. J., Maguire, R., Wilhelm, F., Maniar, M., Jimeno, A., Gomes, C. L., & Messersmith, W. A. (2016). A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 27(6), 1180. https://doi.org/10.1093/annonc/mdw095
O'Neil, B H, et al. "A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer." Annals of oncology : official journal of the European Society for Medical Oncology vol. 27,6 (2016): 1180. doi: https://doi.org/10.1093/annonc/mdw095
O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler AL, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazemzadeh R, Rarick M, Cohen DJ, Radford J, Fehrenbacher L, Bajaj R, Bathini V, Fanta P, Berlin J, McRee AJ, Maguire R, Wilhelm F, Maniar M, Jimeno A, Gomes CL, Messersmith WA. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Ann Oncol. 2016 Jun;27(6):1180. doi: 10.1093/annonc/mdw095. Epub 2016 Mar 03. PMID: 26945010; PMCID: PMC6795379.
Copy Download .nbib Format: NLM
Liquid-Gated High Mobility and Quantum Oscillation of the Two-Dimensional Electron Gas at an Oxide Interface.

ACS nano

Zeng S, Lü W, Huang Z, Liu Z, Han K, Gopinadhan K, Li C, Guo R, Zhou W, Ma HH, Jian L, Venkatesan T, Ariando.
PMID: 26974812
ACS Nano. 2016 Apr 26;10(4):4532-7. doi: 10.1021/acsnano.6b00409. Epub 2016 Mar 14.

Electric field effect in electronic double layer transistor (EDLT) configuration with ionic liquids as the dielectric materials is a powerful means of exploring various properties in different materials. Here, we demonstrate the modulation of electrical transport properties and extremely...

Cite
Zeng S, Lü W, Huang Z, et al. Liquid-Gated High Mobility and Quantum Oscillation of the Two-Dimensional Electron Gas at an Oxide Interface. ACS Nano. 2016;10(4):4532-7doi: 10.1021/acsnano.6b00409.
Zeng, S., Lü, W., Huang, Z., Liu, Z., Han, K., Gopinadhan, K., Li, C., Guo, R., Zhou, W., Ma, H. H., Jian, L., Venkatesan, T., & Ariando. (2016). Liquid-Gated High Mobility and Quantum Oscillation of the Two-Dimensional Electron Gas at an Oxide Interface. ACS nano, 10(4), 4532-7. https://doi.org/10.1021/acsnano.6b00409
Zeng, Shengwei, et al. "Liquid-Gated High Mobility and Quantum Oscillation of the Two-Dimensional Electron Gas at an Oxide Interface." ACS nano vol. 10,4 (2016): 4532-7. doi: https://doi.org/10.1021/acsnano.6b00409
Zeng S, Lü W, Huang Z, Liu Z, Han K, Gopinadhan K, Li C, Guo R, Zhou W, Ma HH, Jian L, Venkatesan T, Ariando. Liquid-Gated High Mobility and Quantum Oscillation of the Two-Dimensional Electron Gas at an Oxide Interface. ACS Nano. 2016 Apr 26;10(4):4532-7. doi: 10.1021/acsnano.6b00409. Epub 2016 Mar 14. PMID: 26974812.
Copy Download .nbib Format: NLM
Novel hydrogel adjuvant based on quaternized chitosan for H5N1 split vaccine.

Journal of controlled release : official journal of the Controlled Release Society

Wu J, Wang YQ, Fan QZ, Wu YB, Ma GH.
PMID: 27005183
J Control Release. 2015 Sep 10;213:e51-2. doi: 10.1016/j.jconrel.2015.05.084. Epub 2015 Aug 19.

No abstract available.

Cite
Wu J, Wang YQ, Fan QZ, et al. Novel hydrogel adjuvant based on quaternized chitosan for H5N1 split vaccine. J Control Release. 2015;213:e51-2doi: 10.1016/j.jconrel.2015.05.084.
Wu, J., Wang, Y. Q., Fan, Q. Z., Wu, Y. B., & Ma, G. H. (2015). Novel hydrogel adjuvant based on quaternized chitosan for H5N1 split vaccine. Journal of controlled release : official journal of the Controlled Release Society, 213e51-2. https://doi.org/10.1016/j.jconrel.2015.05.084
Wu, Jie, et al. "Novel hydrogel adjuvant based on quaternized chitosan for H5N1 split vaccine." Journal of controlled release : official journal of the Controlled Release Society vol. 213 (2015): e51-2. doi: https://doi.org/10.1016/j.jconrel.2015.05.084
Wu J, Wang YQ, Fan QZ, Wu YB, Ma GH. Novel hydrogel adjuvant based on quaternized chitosan for H5N1 split vaccine. J Control Release. 2015 Sep 10;213:e51-2. doi: 10.1016/j.jconrel.2015.05.084. Epub 2015 Aug 19. PMID: 27005183.
Copy Download .nbib Format: NLM
Bumetanide promotes neural precursor cell regeneration and dendritic development in the hippocampal dentate gyrus in the chronic stage of cerebral ischemia.

Neural regeneration research

Xu WS, Sun X, Song CG, Mu XP, Ma WP, Zhang XH, Zhao CS.
PMID: 27335557
Neural Regen Res. 2016 May;11(5):745-51. doi: 10.4103/1673-5374.182700.

Bumetanide has been shown to lessen cerebral edema and reduce the infarct area in the acute stage of cerebral ischemia. Few studies focus on the effects of bumetanide on neuroprotection and neurogenesis in the chronic stage of cerebral ischemia....

Cite
Xu WS, Sun X, Song CG, et al. Bumetanide promotes neural precursor cell regeneration and dendritic development in the hippocampal dentate gyrus in the chronic stage of cerebral ischemia. Neural Regen Res. 2016;11(5):745-51doi: 10.4103/1673-5374.182700.
Xu, W. S., Sun, X., Song, C. G., Mu, X. P., Ma, W. P., Zhang, X. H., & Zhao, C. S. (2016). Bumetanide promotes neural precursor cell regeneration and dendritic development in the hippocampal dentate gyrus in the chronic stage of cerebral ischemia. Neural regeneration research, 11(5), 745-51. https://doi.org/10.4103/1673-5374.182700
Xu, Wang-Shu, et al. "Bumetanide promotes neural precursor cell regeneration and dendritic development in the hippocampal dentate gyrus in the chronic stage of cerebral ischemia." Neural regeneration research vol. 11,5 (2016): 745-51. doi: https://doi.org/10.4103/1673-5374.182700
Xu WS, Sun X, Song CG, Mu XP, Ma WP, Zhang XH, Zhao CS. Bumetanide promotes neural precursor cell regeneration and dendritic development in the hippocampal dentate gyrus in the chronic stage of cerebral ischemia. Neural Regen Res. 2016 May;11(5):745-51. doi: 10.4103/1673-5374.182700. PMID: 27335557; PMCID: PMC4904464.
Copy Download .nbib Format: NLM
Neferine Protects Endothelial Glycocalyx via Mitochondrial ROS in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome.

Frontiers in physiology

Liu XY, Xu HX, Li JK, Zhang D, Ma XH, Huang LN, Lü JH, Wang XZ.
PMID: 29520236
Front Physiol. 2018 Feb 22;9:102. doi: 10.3389/fphys.2018.00102. eCollection 2018.

Damage to the endothelial glycocalyx is a critical factor in increased pulmonary vascular permeability, which is the basic pathological feature of acute respiratory distress syndrome (ARDS). Neferine (Nef), a bisbenzylisoquinoline alkaloid isolated from green seed embryos of

Cite
Liu XY, Xu HX, Li JK, et al. Neferine Protects Endothelial Glycocalyx via Mitochondrial ROS in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome. Front Physiol. 2018;9:102doi: 10.3389/fphys.2018.00102.
Liu, X. Y., Xu, H. X., Li, J. K., Zhang, D., Ma, X. H., Huang, L. N., Lü, J. H., & Wang, X. Z. (2018). Neferine Protects Endothelial Glycocalyx via Mitochondrial ROS in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome. Frontiers in physiology, 9102. https://doi.org/10.3389/fphys.2018.00102
Liu, Xiang-Yong, et al. "Neferine Protects Endothelial Glycocalyx via Mitochondrial ROS in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome." Frontiers in physiology vol. 9 (2018): 102. doi: https://doi.org/10.3389/fphys.2018.00102
Liu XY, Xu HX, Li JK, Zhang D, Ma XH, Huang LN, Lü JH, Wang XZ. Neferine Protects Endothelial Glycocalyx via Mitochondrial ROS in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome. Front Physiol. 2018 Feb 22;9:102. doi: 10.3389/fphys.2018.00102. eCollection 2018. PMID: 29520236; PMCID: PMC5826949.
Copy Download .nbib Format: NLM
Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Li FF, Jiang L, Fu L, Zhu HH, Zhou P, Zhang D, Su XF, Wu JD, Ye L, Ma JH.
PMID: 27995593
Diabetes Ther. 2017 Feb;8(1):177-187. doi: 10.1007/s13300-016-0222-7. Epub 2016 Dec 19.

INTRODUCTION: The objective of this study was to investigate the effect of adding exenatide to continuous subcutaneous insulin infusion (CSII) therapy on the precise insulin doses required by type 2 diabetic patients to maintain glycemic control.METHODS: This was a...

Cite
Li FF, Jiang L, Fu L, et al. Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial. Diabetes Ther. 2016;8(1):177-187doi: 10.1007/s13300-016-0222-7.
Li, F. F., Jiang, L., Fu, L., Zhu, H. H., Zhou, P., Zhang, D., Su, X. F., Wu, J. D., Ye, L., & Ma, J. H. (2017). Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(1), 177-187. https://doi.org/10.1007/s13300-016-0222-7
Li, Feng-Fei, et al. "Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,1 (2017): 177-187. doi: https://doi.org/10.1007/s13300-016-0222-7
Li FF, Jiang L, Fu L, Zhu HH, Zhou P, Zhang D, Su XF, Wu JD, Ye L, Ma JH. Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial. Diabetes Ther. 2017 Feb;8(1):177-187. doi: 10.1007/s13300-016-0222-7. Epub 2016 Dec 19. PMID: 27995593; PMCID: PMC5306121.
Copy Download .nbib Format: NLM
Vitamin D receptor-binding site variants affect prostate cancer progression.

Oncotarget

Lin VC, Huang SP, Ting HJ, Ma WL, Yu CC, Huang CY, Yin HL, Huang TY, Lee CH, Chang TY, Lu TL, Bao BY.
PMID: 29088772
Oncotarget. 2017 May 26;8(43):74119-74128. doi: 10.18632/oncotarget.18271. eCollection 2017 Sep 26.

Vitamin D is an important modulator of cellular proliferation through the vitamin D receptor (VDR) that binds to DNA in the regulatory sequences of target genes. We hypothesized that single nucleotide polymorphisms (SNPs) in VDR-binding sites might affect target...

Cite
Lin VC, Huang SP, Ting HJ, et al. Vitamin D receptor-binding site variants affect prostate cancer progression. Oncotarget. 2017;8(43):74119-74128doi: 10.18632/oncotarget.18271.
Lin, V. C., Huang, S. P., Ting, H. J., Ma, W. L., Yu, C. C., Huang, C. Y., Yin, H. L., Huang, T. Y., Lee, C. H., Chang, T. Y., Lu, T. L., & Bao, B. Y. (2017). Vitamin D receptor-binding site variants affect prostate cancer progression. Oncotarget, 8(43), 74119-74128. https://doi.org/10.18632/oncotarget.18271
Lin, Victor C, et al. "Vitamin D receptor-binding site variants affect prostate cancer progression." Oncotarget vol. 8,43 (2017): 74119-74128. doi: https://doi.org/10.18632/oncotarget.18271
Lin VC, Huang SP, Ting HJ, Ma WL, Yu CC, Huang CY, Yin HL, Huang TY, Lee CH, Chang TY, Lu TL, Bao BY. Vitamin D receptor-binding site variants affect prostate cancer progression. Oncotarget. 2017 May 26;8(43):74119-74128. doi: 10.18632/oncotarget.18271. eCollection 2017 Sep 26. PMID: 29088772; PMCID: PMC5650327.
Copy Download .nbib Format: NLM
Data for outcomes of acute hospital administration of amiodarone and/or lidocaine in shockable patients presenting with out-of-hospital cardiac arrest.

Data in brief

Huang CH, Yu PH, Tsai MS, Chuang PY, Wang TD, Chiang CY, Chang WT, Ma MH, Tang CH, Chen WJ.
PMID: 27942569
Data Brief. 2016 Nov 30;10:57-62. doi: 10.1016/j.dib.2016.11.085. eCollection 2017 Feb.

The data presented in this article are related to the research article entitled "Acute Hospital Administration of Amiodarone and/or Lidocaine in Shockable Patients Presenting with Out-of-hospital Cardiac Arrest: A Nationwide Cohort Study" (C.H. Huang, P.H. Yu, M.S. Tsai et...

Cite
Huang CH, Yu PH, Tsai MS, et al. Data for outcomes of acute hospital administration of amiodarone and/or lidocaine in shockable patients presenting with out-of-hospital cardiac arrest. Data Brief. 2016;10:57-62doi: 10.1016/j.dib.2016.11.085.
Huang, C. H., Yu, P. H., Tsai, M. S., Chuang, P. Y., Wang, T. D., Chiang, C. Y., Chang, W. T., Ma, M. H., Tang, C. H., & Chen, W. J. (2017). Data for outcomes of acute hospital administration of amiodarone and/or lidocaine in shockable patients presenting with out-of-hospital cardiac arrest. Data in brief, 1057-62. https://doi.org/10.1016/j.dib.2016.11.085
Huang, Chien-Hua, et al. "Data for outcomes of acute hospital administration of amiodarone and/or lidocaine in shockable patients presenting with out-of-hospital cardiac arrest." Data in brief vol. 10 (2017): 57-62. doi: https://doi.org/10.1016/j.dib.2016.11.085
Huang CH, Yu PH, Tsai MS, Chuang PY, Wang TD, Chiang CY, Chang WT, Ma MH, Tang CH, Chen WJ. Data for outcomes of acute hospital administration of amiodarone and/or lidocaine in shockable patients presenting with out-of-hospital cardiac arrest. Data Brief. 2016 Nov 30;10:57-62. doi: 10.1016/j.dib.2016.11.085. eCollection 2017 Feb. PMID: 27942569; PMCID: PMC5137177.
Copy Download .nbib Format: NLM
[No title available]

Chronic diseases and translational medicine

Yu SN, Ma YH, Zhao WG, Jin XL, Yang HY, Liu PP, Chen J.
PMID: 29063045
Chronic Dis Transl Med. 2016 Dec 22;2(4):215-222. doi: 10.1016/j.cdtm.2016.11.012. eCollection 2016 Dec.

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a poor overall prognosis. However, curative resection during the early stages of the disease can greatly improve survival rates, highlighting the importance of early screening and detection. Studies of noncoding...

Cite
Yu SN, Ma YH, Zhao WG, et al. . Chronic Dis Transl Med. 2016;2(4):215-222doi: 10.1016/j.cdtm.2016.11.012.
Yu, S. N., Ma, Y. H., Zhao, W. G., Jin, X. L., Yang, H. Y., Liu, P. P., & Chen, J. (2016). . Chronic diseases and translational medicine, 2(4), 215-222. https://doi.org/10.1016/j.cdtm.2016.11.012
Yu, Shuang-Ni, et al. "." Chronic diseases and translational medicine vol. 2,4 (2016): 215-222. doi: https://doi.org/10.1016/j.cdtm.2016.11.012
Yu SN, Ma YH, Zhao WG, Jin XL, Yang HY, Liu PP, Chen J. . Chronic Dis Transl Med. 2016 Dec 22;2(4):215-222. doi: 10.1016/j.cdtm.2016.11.012. eCollection 2016 Dec. PMID: 29063045; PMCID: PMC5643763.
Copy Download .nbib Format: NLM
RNAi targeting Nogo Receptor enhanced survival and proliferation of murine retinal ganglion cells during N-methyl-D-aspartate-induced optic nerve crush.

Oncotarget

Zeng K, Zhong B, Shen XL, Fang M, Lin BT, Ma DH.
PMID: 29029408
Oncotarget. 2017 Apr 21;8(39):65009-65021. doi: 10.18632/oncotarget.17351. eCollection 2017 Sep 12.

We investigated the effects of lentivirus-mediated RNAi targeting of Nogo Receptor (

Cite
Zeng K, Zhong B, Shen XL, et al. RNAi targeting Nogo Receptor enhanced survival and proliferation of murine retinal ganglion cells during N-methyl-D-aspartate-induced optic nerve crush. Oncotarget. 2017;8(39):65009-65021doi: 10.18632/oncotarget.17351.
Zeng, K., Zhong, B., Shen, X. L., Fang, M., Lin, B. T., & Ma, D. H. (2017). RNAi targeting Nogo Receptor enhanced survival and proliferation of murine retinal ganglion cells during N-methyl-D-aspartate-induced optic nerve crush. Oncotarget, 8(39), 65009-65021. https://doi.org/10.18632/oncotarget.17351
Zeng, Kun, et al. "RNAi targeting Nogo Receptor enhanced survival and proliferation of murine retinal ganglion cells during N-methyl-D-aspartate-induced optic nerve crush." Oncotarget vol. 8,39 (2017): 65009-65021. doi: https://doi.org/10.18632/oncotarget.17351
Zeng K, Zhong B, Shen XL, Fang M, Lin BT, Ma DH. RNAi targeting Nogo Receptor enhanced survival and proliferation of murine retinal ganglion cells during N-methyl-D-aspartate-induced optic nerve crush. Oncotarget. 2017 Apr 21;8(39):65009-65021. doi: 10.18632/oncotarget.17351. eCollection 2017 Sep 12. PMID: 29029408; PMCID: PMC5630308.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1233 entries